Literature DB >> 1919694

Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.

M W Fox1, J E Ahlskog, P J Kelly.   

Abstract

Thirty-six patients with Parkinson's disease and medically refractory tremor underwent stereotactic ventrolateralis thalamotomy at the Mayo Clinic between 1984 and 1989. All patients had been or were being treated with carbidopa/levodopa but with unsatisfactory tremor control. Modern stereotactic techniques, including microelectrode recording, were used to treat 36 patients, of whom 31 (86%) had complete abolition of tremor and three patients (5%) had significant improvement. Tremor recurred in two patients within 3 months of surgery; however, the remaining patients suffered no recurrence of tremor during follow-up periods ranging from 14 to 68 months (mean 33 months). Persistent complications (arm dyspraxia, dysarthria, dysphasia, or abulia) were noted in five patients but were a source of disability in only two. It is concluded that thalamotomy in carefully selected patients is a beneficial operation for the control of medically refractory parkinsonian resting tremor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919694     DOI: 10.3171/jns.1991.75.5.0723

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Effective Interventional Magnetic Resonance Image-Guided Laser Ablations in a Parkinson's Disease Patient with Refractory Tremor.

Authors:  Marta San Luciano; Maya Katz; Jill Ostrem; Alastair Martin; Philip Starr; Nathan Ziman; Paul Larson
Journal:  Mov Disord Clin Pract       Date:  2015-12-14

Review 2.  Parkinson's disease.

Authors:  C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

3.  Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

Authors:  P Limousin; J D Speelman; F Gielen; M Janssens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 4.  Gamma knife radiosurgery for movement disorders: a concise review of the literature.

Authors:  Ameer L Elaimy; Benjamin J Arthurs; Wayne T Lamoreaux; John J Demakas; Alexander R Mackay; Robert K Fairbanks; David R Greeley; Barton S Cooke; Christopher M Lee
Journal:  World J Surg Oncol       Date:  2010-07-21       Impact factor: 2.754

Review 5.  A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease.

Authors:  Yuke Zhong; Hang Liu; Guohui Liu; Lili Zhao; Chengcheng Dai; Yi Liang; Juncong Du; Xuan Zhou; Lijuan Mo; Changhong Tan; Xinjie Tan; Fen Deng; Xi Liu; Lifen Chen
Journal:  NPJ Parkinsons Dis       Date:  2022-06-24

Review 6.  Gamma knife radiosurgery for essential tremor: a case report and review of the literature.

Authors:  Ameer L Elaimy; John J Demakas; Benjamin J Arthurs; Barton S Cooke; Robert K Fairbanks; Wayne T Lamoreaux; Alexander R Mackay; David R Greeley; Christopher M Lee
Journal:  World J Surg Oncol       Date:  2010-03-22       Impact factor: 2.754

7.  Outcome of gamma knife thalamotomy in patients with an intractable tremor.

Authors:  Kyung Rae Cho; Hong Rye Kim; Yong Seok Im; Jinyoung Youn; Jin Whan Cho; Jung-Il Lee
Journal:  J Korean Neurosurg Soc       Date:  2015-03-20

8.  Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.

Authors:  Hyun-Man Baik; Bo-Young Choe; Hyoung-Koo Lee; Tae-Suk Suh; Byung-Chul Son; Jae-Mun Lee
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

Review 9.  Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches.

Authors:  Vibhash D Sharma; Margi Patel; Svjetlana Miocinovic
Journal:  Neurotherapeutics       Date:  2020-10-28       Impact factor: 7.620

10.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.